Needham & Company LLC reiterated their hold rating on shares of Paragon 28 (NYSE:FNA – Free Report) in a report published on Wednesday, Marketbeat reports. The brokerage currently has a $13.00 price target on the stock.
A number of other research firms have also issued reports on FNA. William Blair lowered shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Stephens raised shares of Paragon 28 to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, Canaccord Genuity Group dropped their price target on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.60.
View Our Latest Report on Paragon 28
Paragon 28 Trading Up 8.3 %
Paragon 28 (NYSE:FNA – Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.01. The company had revenue of $62.30 million for the quarter, compared to analysts’ expectations of $60.58 million. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The firm’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the business earned ($0.10) EPS. As a group, analysts anticipate that Paragon 28 will post -0.64 earnings per share for the current year.
Insider Buying and Selling at Paragon 28
In related news, major shareholder Mvm Partners, Llc sold 4,256 shares of the company’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $10.00, for a total transaction of $42,560.00. Following the transaction, the insider now owns 10,499,960 shares of the company’s stock, valued at $104,999,600. This represents a 0.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Over the last quarter, insiders sold 300,192 shares of company stock worth $3,135,086. 15.32% of the stock is owned by insiders.
Institutional Trading of Paragon 28
A number of large investors have recently made changes to their positions in the stock. SG Americas Securities LLC lifted its position in Paragon 28 by 40.1% during the fourth quarter. SG Americas Securities LLC now owns 26,754 shares of the company’s stock worth $276,000 after buying an additional 7,653 shares during the period. Ballentine Partners LLC grew its stake in Paragon 28 by 15.0% during the 4th quarter. Ballentine Partners LLC now owns 15,630 shares of the company’s stock valued at $161,000 after purchasing an additional 2,043 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Paragon 28 by 2,141.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after purchasing an additional 749,865 shares in the last quarter. Barclays PLC grew its stake in Paragon 28 by 180.6% during the 3rd quarter. Barclays PLC now owns 84,812 shares of the company’s stock valued at $567,000 after purchasing an additional 54,591 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Paragon 28 by 2.5% in the 3rd quarter. Geode Capital Management LLC now owns 967,519 shares of the company’s stock worth $6,464,000 after acquiring an additional 23,167 shares in the last quarter. Institutional investors and hedge funds own 63.57% of the company’s stock.
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Stories
- Five stocks we like better than Paragon 28
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Rebuilding the Empire: Can Dollar General Rally in 2025?
- What Are Earnings Reports?
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- Upcoming IPO Stock Lockup Period, Explained
- How to Short Sell Stocks Like a Pro: Strategies and Tips
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.